About NeoCura
NeoCura is a company based in Changping (China) founded in 2017 by Wang Yi. NeoCura has raised $38.19 million across 2 funding rounds from investors including CDH, PICC Capital Investment Management and Jiayin Fund. NeoCura operates in a competitive market with competitors including Strand Life Sciences, Helix, Benchling, BioAge Labs and Scholar Rock, among others.
- Headquarter Changping, China
- Founders Wang Yi
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$38.19 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
CDH
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NeoCura
NeoCura has successfully raised a total of $38.19M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NeoCura
NeoCura has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include CDH, PICC Capital Investment Management and Jiayin Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and private debt firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Venture capital firm
|
Locked | Locked | Locked |
Investor details for NeoCura
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NeoCura
Investment portfolio details for NeoCura
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NeoCura
Detailed financials for NeoCura
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neocura Comparisons
Peer comparison for NeoCura
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NeoCura
NeoCura operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Strand Life Sciences, Helix, Benchling, BioAge Labs and Scholar Rock, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Antibody-based drugs for primary myopathies are developed and targeted.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
Detailed competitors of NeoCura
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neocura
Complete news archive for NeoCura
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeoCura
NeoCura was founded in 2017 and raised its 1st funding round 3 years after it was founded.
NeoCura is headquartered in Changping, China. It is registered at Changping, Beijing, China.
Wang Yi is the current CEO of NeoCura. They have also founded this company.
NeoCura is a funded company, having raised a total of $38.19M across 2 funding rounds to date.
NeoCura was founded in 2017 in Changping, China, within the biotechnology sector. Operations focus on AI-integrated platforms that analyze molecular and clinical data for cancer diagnostics and precision medicine. Key offerings include NeoCura for blood-based cancer detection, NeoCura Vac for neoantigen therapeutics guided by AI, and NeoCura Info for multi-omics bioinformatics services. These tools support tumor identification and treatment strategies.
NeoCura's top competitors include Strand Life Sciences, Helix and Benchling.
NeoCura has 7 investors. Key investors include CDH, PICC Capital Investment Management, Jiayin Fund, Zhou Yahui, and IDG Capital.